310 related articles for article (PubMed ID: 7856756)
1. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.
Schofield D; West DC; Anthony DC; Marshal R; Sklar J
Am J Pathol; 1995 Feb; 146(2):472-80. PubMed ID: 7856756
[TBL] [Abstract][Full Text] [Related]
2. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
[TBL] [Abstract][Full Text] [Related]
3. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
[TBL] [Abstract][Full Text] [Related]
5. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
[TBL] [Abstract][Full Text] [Related]
7. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
Emadian SM; McDonald JD; Gerken SC; Fults D
Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.
Albrecht S; von Deimling A; Pietsch T; Giangaspero F; Brandner S; Kleihues P; Wiestler OD
Neuropathol Appl Neurobiol; 1994 Feb; 20(1):74-81. PubMed ID: 8208343
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
Pietsch T; Koch A; Wiestler OD
Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
[TBL] [Abstract][Full Text] [Related]
10. Mutations in SUFU predispose to medulloblastoma.
Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
[TBL] [Abstract][Full Text] [Related]
11. The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.
Cowan R; Hoban P; Kelsey A; Birch JM; Gattamaneni R; Evans DG
Br J Cancer; 1997; 76(2):141-5. PubMed ID: 9231911
[TBL] [Abstract][Full Text] [Related]
12. A YAC contig spanning the nevoid basal cell carcinoma syndrome, Fanconi anaemia group C, and xeroderma pigmentosum group A loci on chromosome 9q.
Morris DJ; Reis A
Genomics; 1994 Sep; 23(1):23-9. PubMed ID: 7829076
[TBL] [Abstract][Full Text] [Related]
13. NBCCS secondary to an interstitial chromosome 9q deletion.
Haniffa MA; Leech SN; Lynch SA; Simpson NB
Clin Exp Dermatol; 2004 Sep; 29(5):542-4. PubMed ID: 15347344
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma in the nevoid basal-cell carcinoma syndrome: case reports and review of the literature.
Lacombe D; Chateil JF; Fontan D; Battin J
Genet Couns; 1990; 1(3-4):273-7. PubMed ID: 2098052
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors.
Xie J; Johnson RL; Zhang X; Bare JW; Waldman FM; Cogen PH; Menon AG; Warren RS; Chen LC; Scott MP; Epstein EH
Cancer Res; 1997 Jun; 57(12):2369-72. PubMed ID: 9192811
[TBL] [Abstract][Full Text] [Related]
17. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
19. A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastomas based on immunolocalization of class III beta-tubulin isotype (beta III) and proliferating cell nuclear antigen (PCNA)/cyclin.
Katsetos CD; Krishna L; Frankfurter A; Karkavelas G; Wolfe DE; Valsamis MP; Schiffer D; Vlachos IN; Urich H
Clin Neuropathol; 1995; 14(2):72-81. PubMed ID: 7606900
[TBL] [Abstract][Full Text] [Related]
20. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
